Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane Lucente

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Cell|April 24, 2012
Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundariesMichael E Talkowski, Jill A Rosenfeld, Ian Blumenthal, et al.
American Journal of Human Genetics|March 6, 2012
Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene regionJong-Min Lee, Tammy Gillis, Jayalakshmi Srinidhi Mysore, et al.
Human Genetics|July 25, 2012
Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onsetEliana Marisa Ramos, Jeanne C Latourelle, Ji-Hyun Lee, et al.
Neurogenetics|May 7, 2013
Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onsetEliana Marisa Ramos, Jeanne C Latourelle, Tammy Gillis, et al.
Biochemical and Biophysical Research Communications|July 10, 2012
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's diseaseJi-Hyun Lee, Jong-Min Lee, Eliana Marisa Ramos, et al.
Biological Psychiatry|February 24, 2020
Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's DiseaseNatalie Ellis, Amelia Tee, Branduff McAllister, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease reveal shared and tissue-specific effects, Jong-Min Lee, Zachariah L McLean, et al.
Cell|August 2, 2022
A cross-disorder dosage sensitivity map of the human genomeRyan L Collins, Joseph T Glessner, Eleonora Porcu, et al.
American Journal of Human Genetics|August 18, 2023
Systematic evaluation of genome sequencing for the diagnostic assessment of autism spectrum disorder and fetal structural anomaliesChelsea Lowther, Elise Valkanas, Jessica L Giordano, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 23, 2019
The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodologyBradley Boeve, Jessica Bove, Patrick Brannelly, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Cell|April 24, 2012
Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundariesMichael E Talkowski, Jill A Rosenfeld, Ian Blumenthal, et al.
American Journal of Human Genetics|March 6, 2012
Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene regionJong-Min Lee, Tammy Gillis, Jayalakshmi Srinidhi Mysore, et al.
Human Genetics|July 25, 2012
Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onsetEliana Marisa Ramos, Jeanne C Latourelle, Ji-Hyun Lee, et al.
Neurogenetics|May 7, 2013
Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onsetEliana Marisa Ramos, Jeanne C Latourelle, Tammy Gillis, et al.
Biochemical and Biophysical Research Communications|July 10, 2012
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's diseaseJi-Hyun Lee, Jong-Min Lee, Eliana Marisa Ramos, et al.
Biological Psychiatry|February 24, 2020
Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's DiseaseNatalie Ellis, Amelia Tee, Branduff McAllister, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease reveal shared and tissue-specific effects, Jong-Min Lee, Zachariah L McLean, et al.
Cell|August 2, 2022
A cross-disorder dosage sensitivity map of the human genomeRyan L Collins, Joseph T Glessner, Eleonora Porcu, et al.
American Journal of Human Genetics|August 18, 2023
Systematic evaluation of genome sequencing for the diagnostic assessment of autism spectrum disorder and fetal structural anomaliesChelsea Lowther, Elise Valkanas, Jessica L Giordano, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 23, 2019
The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodologyBradley Boeve, Jessica Bove, Patrick Brannelly, et al.
Pageof 6